|
US4299814A
(en)
|
1979-05-25 |
1981-11-10 |
Monsanto Company |
Radioimmunoassay of MIF
|
|
JPH0672158B2
(ja)
|
1984-05-24 |
1994-09-14 |
チバ−ガイギ− アクチエンゲゼルシヤフト |
精製されたヒトマクロファージ遊走阻止因子
|
|
US4946674A
(en)
|
1984-10-05 |
1990-08-07 |
Bioferon Biochemische Substanzen Gmbh & Co. |
Process for treatment of rheumatic diseases
|
|
US4708937A
(en)
|
1984-10-15 |
1987-11-24 |
Brigham & Women's Hospital |
Purified migration inhibitory factor also having colony stimulating factor activity
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
ES2052602T3
(es)
|
1986-10-03 |
1994-07-16 |
Ciba Geigy Ag |
Nuevos peptidos afines a las linfocinas.
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
WO1990011301A1
(en)
|
1989-03-17 |
1990-10-04 |
Genetics Institute, Inc. |
Human macrophage migration inhibitory factor
|
|
US5785054A
(en)
|
1989-06-06 |
1998-07-28 |
Kelly; Patrick D. |
Genital lubricant with zinc salt, labelled as anti-viral agent
|
|
GB8915414D0
(en)
|
1989-07-05 |
1989-08-23 |
Ciba Geigy |
Novel cytokines
|
|
EP0457875A4
(en)
|
1989-11-13 |
1993-03-03 |
Xoma Corporation |
Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
|
|
US5227459A
(en)
|
1990-05-18 |
1993-07-13 |
Yale University |
Synthetic melanin
|
|
US5786168A
(en)
|
1990-06-04 |
1998-07-28 |
Kirin Beer Kabushiki Kaisha |
Method for recombinant production of antigen non-specific glycosylation inhibiting factor (GIF)
|
|
US5585479A
(en)
|
1992-07-24 |
1996-12-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human ELAM-I RNA
|
|
US6645493B1
(en)
|
1993-05-17 |
2003-11-11 |
The Picower Institute For Medical Research |
Composition containing anti-MIF antibody
|
|
US6774227B1
(en)
|
1993-05-17 |
2004-08-10 |
Cytokine Pharmasciences, Inc. |
Therapeutic uses of factors which inhibit or neutralize MIF activity
|
|
JP4708510B2
(ja)
|
1993-05-17 |
2011-06-22 |
サイトカイン ファーマサイエンシズ，インコーポレーテッド |
サイトカイン媒介毒性に関係する疾患の治療における遊走阻止因子の抑制
|
|
US5559028A
(en)
|
1993-05-19 |
1996-09-24 |
Antigen Express, Inc. |
Methods of enhancing or antigen presentation to T cells inhibiting
|
|
EP0770086A4
(en)
|
1994-05-16 |
1998-07-15 |
Human Genome Sciences Inc |
MACROPHAGE MIGRATION INHIBITING FACTOR-3
|
|
US5747023A
(en)
|
1994-07-01 |
1998-05-05 |
Genentech, Inc. |
Cancer therapy using lymphotoxin
|
|
SI9400363A
(en)
|
1994-09-19 |
1996-08-31 |
Mozetic Francky Bojana |
Human macrophage migration inhibitory factor of nonlymphoid origin, expression of mif in e. coli and purification of recombinant protein
|
|
AU4365796A
(en)
|
1994-11-16 |
1996-06-06 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor
|
|
JPH0977799A
(ja)
|
1995-09-13 |
1997-03-25 |
Sapporo Immuno Diagnostic Lab:Kk |
ヒト−マクロファージ遊走阻止因子（ヒト−ｍｉｆ）に対するモノクローナル抗体および該抗体を産生するハイブリドーマ
|
|
WO1997025344A1
(en)
|
1996-01-03 |
1997-07-17 |
The Australian National University |
Clip analogues and autoimmune disease
|
|
US6492428B1
(en)
|
2000-07-26 |
2002-12-10 |
The Picower Institute For Medical Research |
Compounds having MIF antagonist activity
|
|
US6420188B1
(en)
|
1996-02-16 |
2002-07-16 |
The Picower Institute For Medical Research |
Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
|
|
US5726020A
(en)
|
1996-06-11 |
1998-03-10 |
University Of Massachusetts |
Inhibition of II synthesis
|
|
US6297253B1
(en)
|
1996-10-15 |
2001-10-02 |
The Picower Institute For Medical Research |
Compounds and methods of use to treat infectious diseases
|
|
US6326465B1
(en)
|
1997-02-24 |
2001-12-04 |
The Johns Hopkins University |
Immunomodulatory polypeptides derived from the invariant chain of MHC class II
|
|
JP3835827B2
(ja)
|
1997-05-02 |
2006-10-18 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ リプレゼンティッド バイ ザ セクレタリーオブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
悪性細胞に対する、ｏｎｃタンパク質を含む、免疫毒素
|
|
CA2205680A1
(en)
|
1997-05-16 |
1998-11-16 |
The University Of Western Ontario |
Clip immunomodulatory peptide
|
|
US6011005A
(en)
|
1997-09-18 |
2000-01-04 |
The Picower Institute For Medical Research |
Prevention of pregnancy miscarriages
|
|
AU747767B2
(en)
|
1997-11-05 |
2002-05-23 |
University Of Southern California |
Use of cytokines and mitogens to inhibit pathological immune responses
|
|
EP1156823B1
(en)
|
1999-02-12 |
2008-10-29 |
The Scripps Research Institute |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
|
|
CA2389229A1
(en)
|
1999-10-29 |
2001-05-10 |
The Picower Institute For Medical Research |
Compounds having mif antagonist activity
|
|
US6268151B1
(en)
|
2000-01-20 |
2001-07-31 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of macrophage migration inhibitory factor expression
|
|
WO2001064749A2
(en)
*
|
2000-02-28 |
2001-09-07 |
Idec Pharmaceuticals Corporation |
Method for preparing anti-mif antibodies
|
|
DK1383919T3
(da)
|
2001-03-29 |
2010-11-08 |
Cytokine Pharmasciences Inc |
Fremgangsmåder og sammensætninger til anvendelse af MHC klasse II-invariant kædepolypeptid som en receptor for makrofag migrationsinhiberede faktor
|
|
UY27304A1
(es)
|
2001-05-24 |
2002-12-31 |
Avanir Pharmaceuticals |
Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
|
|
US7205107B2
(en)
|
2001-12-21 |
2007-04-17 |
Cytokine Pharmasciences, Inc. |
Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease
|
|
US20050202010A1
(en)
|
2003-08-29 |
2005-09-15 |
Giroir Brett P. |
Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
|
|
US8883160B2
(en)
|
2004-02-13 |
2014-11-11 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
|
SG153825A1
(en)
|
2005-12-16 |
2009-07-29 |
Ibc Pharmaceuticals Inc |
Multivalent immunoglobulin-based bioactive assemblies
|
|
CN100457895C
(zh)
|
2006-05-24 |
2009-02-04 |
中国科学院生物物理研究所 |
鼠抗人巨噬细胞迁移抑制因子单克隆抗体及其应用
|
|
US20090220521A1
(en)
*
|
2008-01-04 |
2009-09-03 |
Randolf Kerschbaumer |
Anti MIF Antibodies
|
|
EP2079202A1
(en)
*
|
2008-01-08 |
2009-07-15 |
NEC Corporation |
Method for optimizing the triggering of the transmission of buffer status reporting (BSR) information
|
|
WO2011090492A1
(en)
|
2010-01-19 |
2011-07-28 |
Immunomedics, Inc. |
Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
|
|
US9958456B2
(en)
|
2011-10-07 |
2018-05-01 |
Baxalta Incorporated |
OxMIF as a diagnostic marker
|
|
WO2013050457A1
(en)
|
2011-10-07 |
2013-04-11 |
Baxter Healthcare S.A. |
Characterization of cho-mif gene and protein, and use thereof
|